NFSG
PACB icon

Newbridge Financial Services Group’s Pacific Biosciences PACB Stock Holding History

Newbridge Financial Services Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,000
Closed -$7.68K – 1371
2025
Q3 		$7.68K Hold
6,000
– – ﹤0.01% 948
2025
Q2 		$7.44K Hold
6,000
– – ﹤0.01% 952
2025
Q1 		$7.08K Hold
6,000
– – ﹤0.01% 744
2024
Q4 		$11K Hold
6,000
– – ﹤0.01% 715
2024
Q3 		$10.2K Hold
6,000
– – ﹤0.01% 427
2024
Q2 		$8.22K Buy
+6,000
New +$12.1K ﹤0.01% 746
2022
Q2 		– Sell
-957
Closed -$9K – 1475
2022
Q1 		$9K Buy
957
+558
+140% +$6.42K ﹤0.01% 968
2021
Q4 		$8K Buy
+399
New +$9.63K ﹤0.01% 973

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return